The current status and future of ADC therapy for small cell Lung Cancer: a promising approach
Among the subset of 9 patients, a remarkable response rate of 77.8% was observed, with 7 patients showing partial responses (PRs). [...]ADCs offer a promising and rapidly evolving therapeutic strategy for the treatment of SCLC. Continued research and development efforts in these areas are expected t...
Saved in:
Published in | Journal of translational medicine Vol. 21; no. 1; pp. 1 - 808 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central Ltd
13.11.2023
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Among the subset of 9 patients, a remarkable response rate of 77.8% was observed, with 7 patients showing partial responses (PRs). [...]ADCs offer a promising and rapidly evolving therapeutic strategy for the treatment of SCLC. Continued research and development efforts in these areas are expected to further improve the efficacy and safety of ADCs, ultimately benefiting patients with SCLC in clinical practice. |
---|---|
Bibliography: | SourceType-Other Sources-1 ObjectType-Article-2 content type line 63 ObjectType-Correspondence-1 |
ISSN: | 1479-5876 1479-5876 |
DOI: | 10.1186/s12967-023-04471-2 |